The dengue virus NS1 protein conveys pro-inflammatory signals by docking onto human high-density lipoproteins

The nonstructural NS1 protein is a virulence factor secreted by dengue virus (DENV)-infected cells. NS1 is known to alter the complement system, activate immune cells and perturb endothelial barriers. Here we show that pro-inflammatory signals are triggered by a high affinity complex formed between NS1 and human high-density lipoproteins (HDL). Electron microscopy images of the NS1-HDL complexes show spherical HDL particles with rod-shaped NS1 protrusions on their surface. These complexes are readily detectable in the plasma of hospitalized dengue patients using anti-apolipoprotein A-I (ApoA-I) antibodies specific of the HDL moiety. The functional reprogramming of HDL particles by the NS1 protein as a means to exacerbate systemic inflammation during DENV infection provides a new paradigm linking the human lipoprotein network to dengue pathogenesis.

[1]  E. Undurraga,et al.  Persistence of symptoms in dengue patients: a clinical cohort study. , 2020, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[2]  X. Su,et al.  The exchangeable apolipoproteins in lipid metabolism and obesity. , 2020, Clinica chimica acta; international journal of clinical chemistry.

[3]  V. Cardoso,et al.  Serum lipid profile as a predictor of dengue severity: A systematic review and meta‐analysis , 2019, Reviews in medical virology.

[4]  C. Sirois,et al.  Inflammatory status and severity of disease in dengue patients are associated with lipoprotein alterations , 2019, PloS one.

[5]  E. Harris,et al.  Cyclic Dinucleotide–Adjuvanted Dengue Virus Nonstructural Protein 1 Induces Protective Antibody and T Cell Responses , 2019, The Journal of Immunology.

[6]  E. Harris,et al.  Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease Tropism , 2019, Cell reports.

[7]  A. Marais Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease. , 2019, Pathology.

[8]  G. Ogg,et al.  Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection , 2018, Nature Communications.

[9]  D. Sanoudou,et al.  Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis , 2018, Journal of personalized medicine.

[10]  E. Harris,et al.  The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis. , 2018, Annual review of virology.

[11]  C. Mok,et al.  Serum Cytokine Profiles in Patients with Dengue Fever at the Acute Infection Phase , 2018, Disease markers.

[12]  J. Heinecke,et al.  Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions? , 2018, Expert review of proteomics.

[13]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[14]  S. Urcuqui-Inchima,et al.  [Modulation of high-density lipoprotein and cytokine IL-1β and IL-6 levels in patients with dengue]. , 2018, Revista peruana de medicina experimental y salud publica.

[15]  A. Brault,et al.  A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model , 2017, Scientific Reports.

[16]  G. N. Nascentes,et al.  Prospective study of patients with persistent symptoms of dengue in Brazil , 2017, Revista do Instituto de Medicina Tropical de Sao Paulo.

[17]  T. Weichhart,et al.  Pro- versus Anti-inflammatory Actions of HDLs in Innate Immunity. , 2017, Cell metabolism.

[18]  Marion C Lanteri,et al.  Serum from dengue virus-infected patients with and without plasma leakage differentially affects endothelial cells barrier function in vitro , 2017, PloS one.

[19]  K. Stacey,et al.  Dengue virus NS1 protein activates immune cells via TLR4 but not TLR2 or TLR6 , 2017, Immunology and cell biology.

[20]  A. Rothman,et al.  Immune-mediated cytokine storm and its role in severe dengue , 2017, Seminars in Immunopathology.

[21]  K. Abhishek,et al.  Association of interleukin-2, -4 and -10 with dengue severity , 2017, Indian journal of pathology & microbiology.

[22]  A. Wilder-Smith,et al.  Markers of dengue severity: a systematic review of cytokines and chemokines. , 2016, Journal of General Virology.

[23]  F. Scholle,et al.  Dengue virus NS1 enhances viral replication and pro-inflammatory cytokine production in human dendritic cells. , 2016, Virology.

[24]  R. Mohana-Borges,et al.  Inhibition of the Membrane Attack Complex by Dengue Virus NS1 through Interaction with Vitronectin and Terminal Complement Proteins , 2016, Journal of Virology.

[25]  Sunit K. Singh,et al.  Flavivirus NS1: a multifaceted enigmatic viral protein , 2016, Virology Journal.

[26]  E. Harris,et al.  Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability , 2016, PLoS pathogens.

[27]  C. Kalogeropoulou,et al.  Distinct Roles of Apolipoproteins A1 and E in the Modulation of High-Density Lipoprotein Composition and Function. , 2016, Biochemistry.

[28]  P. Young,et al.  The many faces of the flavivirus NS1 protein offer a multitude of options for inhibitor design. , 2016, Antiviral research.

[29]  G. Dernick,et al.  Cholesteryl ester transfer between lipoproteins does not require a ternary tunnel complex with CETP. , 2016, Journal of structural biology.

[30]  G. Screaton,et al.  Recent advances in understanding dengue , 2016, F1000Research.

[31]  Yee‐Shin Lin,et al.  Anti-dengue virus nonstructural protein 1 antibodies contribute to platelet phagocytosis by macrophages , 2015, Thrombosis and Haemostasis.

[32]  V. Herrera,et al.  Characterization of the health condition of people convalescing from a dengue episode. , 2015, Biomedica : revista del Instituto Nacional de Salud.

[33]  Anja Boisen,et al.  Quantification of NS1 dengue biomarker in serum via optomagnetic nanocluster detection , 2015, Scientific Reports.

[34]  D. Hume,et al.  Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity , 2015, Science Translational Medicine.

[35]  Eva Harris,et al.  Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination , 2015, Science Translational Medicine.

[36]  A. Sakuntabhai,et al.  Value of Routine Dengue Diagnostic Tests in Urine and Saliva Specimens , 2015, PLoS neglected tropical diseases.

[37]  E. Harris,et al.  Lower Low-Density Lipoprotein Cholesterol Levels Are Associated with Severe Dengue Outcome , 2015, PLoS neglected tropical diseases.

[38]  Shobini Jayaraman,et al.  Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL[S] , 2015, Journal of Lipid Research.

[39]  J. Chu,et al.  Activation of TLR2 and TLR6 by Dengue NS1 Protein and Its Implications in the Immunopathogenesis of Dengue Virus Infection , 2015, PLoS pathogens.

[40]  B. Kleuser,et al.  The role of serum amyloid A and sphingosine-1-phosphate on high-density lipoprotein functionality , 2015, Biological chemistry.

[41]  R. Kuhn,et al.  Structure‐guided insights on the role of NS1 in flavivirus infection , 2015, BioEssays : news and reviews in molecular, cellular and developmental biology.

[42]  Indra Ramasamy,et al.  Recent advances in physiological lipoprotein metabolism , 2014, Clinical chemistry and laboratory medicine.

[43]  M. Schittmayer,et al.  Understanding high-density lipoprotein function in disease: recent advances in proteomics unravel the complexity of its composition and biology. , 2014, Progress in lipid research.

[44]  S. Vilcarromero,et al.  Occurrence and correlates of symptom persistence following acute dengue fever in Peru. , 2014, The American journal of tropical medicine and hygiene.

[45]  F. Turrini,et al.  Proteomic Analysis of Plasma-Purified VLDL, LDL, and HDL Fractions from Atherosclerotic Patients Undergoing Carotid Endarterectomy: Identification of Serum Amyloid A as a Potential Marker , 2013, Oxidative medicine and cellular longevity.

[46]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[47]  M. Saemann,et al.  Inflammation alters HDL composition and function: implications for HDL-raising therapies. , 2013, Pharmacology & therapeutics.

[48]  G. Ren,et al.  Optimized negative-staining electron microscopy for lipoprotein studies. , 2013, Biochimica et biophysica acta.

[49]  S. Sekaran,et al.  Cytokine Expression Profile of Dengue Patients at Different Phases of Illness , 2012, PloS one.

[50]  Sjors H.W. Scheres,et al.  RELION: Implementation of a Bayesian approach to cryo-EM structure determination , 2012, Journal of structural biology.

[51]  Trai-Ming Yeh,et al.  Dengue virus nonstructural protein NS1 binds to prothrombin/thrombin and inhibits prothrombin activation. , 2012, The Journal of infection.

[52]  A. Kontush,et al.  Biological activities of HDL subpopulations and their relevance to cardiovascular disease. , 2011, Trends in molecular medicine.

[53]  J. d'Alayer,et al.  Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein , 2011, Proceedings of the National Academy of Sciences.

[54]  W. Hörl,et al.  The versatility of HDL: a crucial anti‐inflammatory regulator , 2010, European journal of clinical investigation.

[55]  Ryo Takano,et al.  A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection. , 2010, Antiviral research.

[56]  J. Suvarna,et al.  Serum lipid profile: a predictor of clinical outcome in dengue infection , 2009, Tropical medicine & international health : TM & IH.

[57]  K. Ikuta,et al.  Secreted complement regulatory protein clusterin interacts with dengue virus nonstructural protein 1. , 2007, Biochemical and biophysical research communications.

[58]  C. King,et al.  Antiplatelet autoantibodies elicited by dengue virus non‐structural protein 1 cause thrombocytopenia and mortality in mice , 2007, Journal of thrombosis and haemostasis : JTH.

[59]  A. Falconar Antibody Responses Are Generated to Immunodominant ELK/KLE-Type Motifs on the Nonstructural-1 Glycoprotein during Live Dengue Virus Infections in Mice and Humans: Implications for Diagnosis, Pathogenesis, and Vaccine Design , 2007, Clinical and Vaccine Immunology.

[60]  M. Guzmán,et al.  Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever‐dengue shock syndrome (DHF/DSS) , 2007, Immunology and cell biology.

[61]  G. Nybakken,et al.  West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H , 2006, Proceedings of the National Academy of Sciences.

[62]  S. Green,et al.  Immunopathological mechanisms in dengue and dengue hemorrhagic fever , 2006, Current opinion in infectious diseases.

[63]  R. Césaire,et al.  Evaluation of an Enzyme Immunoassay for Detection of Dengue Virus NS1 Antigen in Human Serum , 2006, Clinical and Vaccine Immunology.

[64]  Yee‐Shin Lin,et al.  Autoimmune pathogenesis in dengue virus infection. , 2006, Viral immunology.

[65]  S. Vasudevan,et al.  Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever , 2006, Reviews in medical virology.

[66]  P. Brown,et al.  Macromolecular size-and-shape distributions by sedimentation velocity analytical ultracentrifugation. , 2006, Biophysical journal.

[67]  M. Blettner,et al.  Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. , 2006, The Journal of infectious diseases.

[68]  A. Talarmin,et al.  Secretion of flaviviral non-structural protein NS1: from diagnosis to pathogenesis. , 2006, Novartis Foundation symposium.

[69]  C. Thiemermann,et al.  Lipoproteins in inflammation and sepsis. I. Basic science , 2006, Intensive Care Medicine.

[70]  Sjors H W Scheres,et al.  SPI-EM: towards a tool for predicting CATH superfamilies in 3D-EM maps. , 2005, Journal of molecular biology.

[71]  I. Kurane,et al.  In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection. , 2004, Journal of virological methods.

[72]  C. Thiemermann,et al.  High-Density Lipoproteins in Sepsis and Septic Shock: Metabolism, Actions, and Therapeutic Applications , 2004, Shock.

[73]  A. Nisalak,et al.  High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. , 2002, The Journal of infectious diseases.

[74]  J. V. D. van der Meer,et al.  Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic fever. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[75]  V. Deubel,et al.  Enzyme-Linked Immunosorbent Assay Specific to Dengue Virus Type 1 Nonstructural Protein NS1 Reveals Circulation of the Antigen in the Blood during the Acute Phase of Disease in Patients Experiencing Primary or Secondary Infections , 2002, Journal of Clinical Microbiology.

[76]  J. Lepault,et al.  Dengue Virus Type 1 Nonstructural Glycoprotein NS1 Is Secreted from Mammalian Cells as a Soluble Hexamer in a Glycosylation-Dependent Fashion , 1999, Journal of Virology.

[77]  C. Rice,et al.  trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication , 1997, Journal of virology.

[78]  V. Deubel,et al.  Purification and renaturation of Japanese encephalitis virus nonstructural glycoprotein NS1 overproduced by insect cells. , 1995, Protein expression and purification.

[79]  V. Stollar,et al.  Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization. , 1989, Virology.

[80]  J. Schlesinger,et al.  Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. , 1987, The Journal of general virology.

[81]  C. Rice,et al.  Molecular biology of the flaviviruses. , 1987, Microbiological sciences.

[82]  J. Schlesinger,et al.  Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. , 1985, Journal of immunology.

[83]  R. Cardiff,et al.  Dengue Virions and Antigens in Brain and Serum of Infected Mice , 1970, Journal of virology.